Cystic Fibrosis Group Raises Concerns About Drug Access

Headline Politics

Cystic Fibrosis Group Raises Concerns About Drug Access

At a news conference in Ottawa, representatives from Cystic Fibrosis Canada raise concerns about proposed changes to drug-pricing provisions in the Patented Medicines Regulations, which they say could hinder patients’ access to new medications. (March 11, 2020)